ArticleProceedings of the National Academy of Sciences of the United States of America2019
Enabling microbial syringol conversion through structure-guided protein engineering.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 65 citations in OpenAlex.
- Reimagining Lignin Valorization: Synthetic Biology-Enabled Sustainable Aromatic Carbon Biomanufacturing.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Differential membrane lipid disruption by lipopeptide antibiotics, colistin and turnercyclamycins.Nature communications · 2026Article
- Rewiring Aromatic Compound Consumption: Chromosomal Amplification and Evolution of a Foreign Pathway inACS synthetic biology · 2025Article
- Obtaining PDC and other high-added value products from lignin byJournal of integrative bioinformatics · 2025Article
- Structural insights into S-lignin O-demethylation via a rare class of heme peroxygenase enzymes.Nature communications · 2025Article
- Lignin valorization to bioplastics with an aromatic hub metabolite-based autoregulation system.Nature communications · 2024Article
- The catabolism of lignin-derivedApplied and environmental microbiology · 2024Article
- Electrocatalytic valorization of lignocellulose-derived aromatics at industrial-scale current densities.Nature communications · 2023Article
- A keyApplied and environmental microbiology · 2023Article
- Draft Genome Assembly ofMicrobiology resource announcements · 2023Article
- Impact of the T296S mutation in P450 GcoA for aryl-O-demethylation: a QM/MM study.Frontiers in chemistry · 2023Article
- Allyl Aryl Ether Cleavage byMicrobiology spectrum · 2022Article
- Single-Site Mutation Induces Water-Mediated Promiscuity in Lignin Breaking Cytochrome P450ACS omega · 2022Article
- Protein Engineering of an Artificial P450BM3 Peroxygenase System Enables Highly SelectiveMolecules (Basel, Switzerland) · 2022Article
- A Unique P450 Peroxygenase System Facilitated by a Dual-Functional Small Molecule: Concept, Application, and Perspective.Antioxidants (Basel, Switzerland) · 2022Review
- Article
- Cytochromes P450 in the biocatalytic valorization of lignin.Current opinion in biotechnology · 2022Review
- Structural Transformation and Creativity Induced by Biological Agents during Fermentation of Edible Nuts fromMolecules (Basel, Switzerland) · 2021Article
- Valorization of lignin components into gallate by integrated biological hydroxylation, O-demethylation, and aryl side-chain oxidation.Science advances · 2021Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 7 institutions in 2 countries.
Funding
Abstract
Microbial conversion of aromatic compounds is an emerging and promising strategy for valorization of the plant biopolymer lignin. A critical and often rate-limiting reaction in aromatic catabolism is
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.